January 2nd 2024
By Alex Biese
From Jimmy Buffett's death to the chemo shortage and cannabis use in cancer care, here is a look back at some of our most popular oncology stories from 2023.
December 20th 2023
By Brielle Benyon
The use best use of opioids or NSAIDS may vary based on the type of pain patients with cancer are experiencing, recent research found.
December 19th 2023
By Colleen Moretti
Breast cancer treatment can disrupt patients’ quality and quantity of sleep, leaving them fatigued and restless during the day.
December 4th 2023
By Rylan DeStefano
A recent study showed that incorporating immunotherapy checkpoint blockade into treatment before and after surgery can increase treatment-related side effects.
November 25th 2023
By Ashley Chan
The FDA granted an orphan drug designation for the novel drug, NT-17, to treat people with acute radiation syndrome.
November 22nd 2023
Receiving palliative care is important for adolescent and young adult patients, as they experience a time of identity development, an expert told CURE®.
November 11th 2023
A phase 3 trial found that testosterone recovery after androgen deprivation therapy leads to better quality of life following high-risk prostate cancer.
November 6th 2023
By Darlene Dobkowski, MA
Managing side effects from lung cancer treatment with dose reductions is an approach experts have been using more, even though some patients voice concerns about lowering a drug’s impact on the disease.
October 24th 2023
One expert explains why palliative care for patients with cancer “is about aligning the patient's goals and the family's goals with the therapeutic goals.”
October 18th 2023
The benefit of neurofeedback by a closed-loop brain-computer interface was prominent when treating chemotherapy-induced peripheral neuropathy in patients with breast cancer.
Cancer Survivor Raises AYA Awareness After Rare Lymphoma Diagnosis
An Expert Offers Advice and Resources for Navigating Rare Lymphoma
Celebrating an Expert at Emotional Support
Dr. Eng Breaks Down Braftovi Plus Erbitux FDA Approval in BRAF+ mCRC